On Wednesday, Shares of Pfizer Inc. (NYSE:PFE), lost -0.83% to $33.45.
Pfizer’s Centers for Therapeutic Innovation (CTI) and the Jeffrey Modell Foundation (JMF) declared recently a partnership agreement to conduct research in the field of immunological diseases. CTI and JMF will identify and co-fund translational research projects with leading academic medical centers within the CTI network. The aim of each research project will be to identify and validate a potential drug candidate for an immunological disease that can be moved into further clinical testing.
“Accelerating drug discovery is the aim of every CTI partnership and this agreement aligns with two of our core therapeutic areas, immunology and rare diseases, where we have leading expertise and a long history in research and bringing treatments to patients,” said Anthony J. Coyle, senior vice president and CTI’s chief scientific officer. “With a deeply committed partner like the Jeffrey Modell Foundation, we have an opportunity to leverage our respective expertise to assist enhance our understanding of the complex immune system, which plays a key role in many rare diseases.”
The partnership with CTI represents JMF’s first alliance with a biopharmaceutical company. “We are excited about the opportunity to collaborate with Pfizer as we broaden our commitment to make a world of difference in the lives of patients with immunological diseases,” said Vicki Modell, co-founder of the Jeffrey Modell Foundation. “JMF’s expertise in Primary Immunodeficiency and extensive network of collaborators, combined with Pfizer’s impressive research and development capabilities has the potential to identify and advance novel research projects. Together, we hope to make meaningful advancements in our understanding of immunological diseases.”
Pfizer Inc., a biopharmaceutical company, discovers, develops, manufactures, and sells healthcare products worldwide. The company operates through Global Innovative Pharmaceutical (GIP); Global Vaccines, Oncology and Consumer Healthcare (VOC); and Global Established Pharmaceutical (GEP) segments.
Shares of American Express Company (NYSE:AXP), declined -2.09% to $75.93, during its last trading session, hitting its lowest level.
American Express Company, declared the redesigned U.S. Amex® Mobile app for iPhone and Android. Accessible for Personal, Small Business and Corporate Card Members, the redesigned app comprises the convenience of Touch ID™ login, nearby offers on a map, rewards information and unique mobile service features like on-the-spot fraud alert verification.
The updated features and modern design allow users to make the most of their American Express Membership. The app not only makes it simple to pay your bill on the go, but also provides value to our Card Members with a broad set of features:
- Sign in faster with Touch ID for supported devices with iOS 8+
- Stay on top of spending:
- View payment status when you log in
- Access real time transaction activity (pending and posted charges) in a timeline
- Access Benefits and Rewards:
- View Card benefits and Membership Reward® balances
- Use Membership Rewards points for eligible charges in the app. Terms apply.
- Discover nearby Amex Offers for shopping, dining and travel
- Get instant fraud alerts and verify charges right in the app.
American Express Company, together with its auxiliaries, provides charge and credit payment card products and travel-related services to consumers and businesses worldwide. The company operates through four segments: U.S. Card Services, International Card Services, Global Commercial Services, and Global Network & Merchant Services.
Finally, ITC Holdings Corp. (NYSE:ITC), ended its last trade with -0.54% loss, and closed at $33.30.
ITC Holdings Corp., declared that Matthew Dills has joined the company as vice president, human resources and chief human resources officer. Dills will lead all human resources functions for ITC.
“Matthew’s knowledge across a number of industries aligns with our corporate culture of operational excellence and will be an invaluable resource at ITC,” said Joseph Welch, chairman, president and CEO of ITC. “We are truly happy that someone with his level of experience and skill has joined the ITC team.”
Dills served as executive vice president of human resources and talent administration at Hylant Inc., where he partnered with executive leadership to lead the human resource strategy and business partnership across the enterprise. Preceding to that, he held several positions with First Solar, Inc., counting vice president of human resources, talent, learning and organizational development. While at First Solar he offered business partnership focus and planned deployment of human resources (HR) services, counting employee/labor relations, compensation, recruitment, and training/organizational development. He also served as senior director of human resources for The University of Toledo, where he drove the planned development of HR services, counting employee relations, compensation, recruitment, and HRIS.
Dills holds a Juris Doctor in Law from The University of Toledo, College of Law, and a Master of Arts in Industrial / Organizational Psychology from the University of New Haven. He also holds a Bachelor of Arts from Bowling Green State University.
ITC Holdings Corp., together with its auxiliaries, engages in the transmission of electricity in the United States. The company functions as conduit, allowing for power from generators to be transmitted to local distribution systems through its own systems or in conjunction with neighboring transmission systems.
DISCLAIMER:
This article is published by www.wsnewspublishers.com. The Content included in this article is just for informational purposes only. All information used in this article is believed to be from reliable sources, but we make no representations or warranties of any kind, express or implied, about the completeness, accuracy, or reliability with respect to this article.
All visitors are advised to conduct their own independent research into individual stocks before making a purchase decision.
Information contained in this article contains forward-looking information within the meaning of Section 27A of the Securities Act of 1933 and Section 21E of the Securities Exchange Act of 1934, counting statements regarding the predictable continual growth of the market for the corporation’s products, the corporation’s ability to fund its capital requirement in the near term and in the long term; pricing pressures; etc.
Any statements that express or involve discussions with respect to predictions, expectations, beliefs, plans, projections, objectives, aims, assumptions, or future events or performance may be forward looking statements. Forward-looking statements are based on expectations, estimates, and projections at the time the statements are made that involve a number of risks and uncertainties which could cause actual results or events to differ materially from those presently anticipated. Forward looking statements may be identified through the use of such words as expects, will, anticipates, estimates, believes, or by statements indicating certain actions may, could, should/might occur.
